Correction | GenomeWeb


Harry Glorikian, who was interviewed on the PCR market in last week's edition, is a partner with TSG-Partners, a life-sciences strategic consultancy. Additionally, the firm served as an advisor to Atto Bioscience, not Becton Dickinson, in the firm's July 2004 merger transaction.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.